Keyword: Sanofi Genzyme due diligence

News

Henri Termeer To Leave Genzyme With About $160 Million

08.03.2011 - Genzyme Chief Executive Henri Termeer is set to walk away with nearly $160 million when the sale of his company to French drugmaker Sanofi-Aventis is final - and stands to earn...

News

Sanofi Could Announce Genzyme Deal Next Week

03.02.2011 - French drugmaker Sanofi-Aventis could announce a deal to buy U.S. biotech Genzyme early next week if final negotiations between the companies go smoothly, Le Figaro reported on...

News

Sanofi Puts Genzyme At Low $70s Plus Payout

02.02.2011 - France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70s-per-share range, plus a milestone payment based on the performance of an experimental drug, a...

News

Genzyme, Sanofi Reach Agreement in Principle on Takeover Terms

01.02.2011 - U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...